Latest industry research report on: Global Glaucoma Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts
Glaucoma
is a group of eye diseases which result in damage to the optic nerve
and vision loss. The most common type is open-angle glaucoma with less
common types including closed-angle glaucoma and normal-tension
glaucoma. Open-angle glaucoma develops slowly over time and there is no
pain. Side vision may begin to decrease followed by central vision
resulting in blindness, if not treated. Closed-angle glaucoma can
present gradually or suddenly. The sudden presentation may involve
severe eye pain, blurred vision, mid-dilated pupil, redness of the eye,
and nausea. Vision loss from glaucoma, once it has occurred, is
permanent.
Though,
glaucoma cannot be cured completely but the disease progression can be
controlled with the help of available treatments. There are three types
of modalities available for treatment of glaucoma: Drugs, Laser and
Invasive Surgery. Further, based upon the approaches employed for the
medication, it can be segmented into two parts: PGA Medication and
Non-PGA Medication. The PGA approach reduces IOP with the help of
prostaglandin (PGA). The non-PGA medication can be further divided into
four sub segments: Beta blockers, Alpha blockers, Carbonic anhydrase
inhibitors (CAIs) and Combination Products.
Several
factors such as rising prevalence of diabetes, growing geriatric
population and rising health care expenditure along with increasing
disposable income and growing obese population will drive the market
growth in the next few years. Development of new drugs & devices and
drug therapy focused upon IOP are the few notable market trends.
However, high cost of treatment, severe side effects and hasty drug
approval processes act as a major roadblock for the market growth.
The
report “Global Glaucoma Market: Industry Analysis & Outlook
(2017-2021)” analyzes the development of this market, with focus on the
US and OUS treatment market. The major trends, growth drivers as well as
issues being faced by the market are discussed in detail in this
report. The four major players: Pfizer Inc., Novartis AG, Merck &
Co., Inc. and Allergan Plc. are being profiled along with their key
financials and strategies for growth. The report contains a
comprehensive analysis of the global glaucoma market along with the
study of the US market.
Table of Contents
1. Overview
1.1 Glaucoma
1.2 Causes & Types
1.3 Symptoms & Diagnosis
1.4 Treatment Methods
1.5 Glaucoma Pharmaceutical Market Segmentation
2. Global Glaucoma Market
2.1 Global Glaucoma Market Forecast by Value
2.2 Global Glaucoma Market by Segments
2.3 Global Glaucoma Drugs Market Forecast by Value
2.4 Global Glaucoma Market by Drug Class
2.5 Global Glaucoma Drugs Market by Region
2.6 Global Glaucoma Patient Volume Forecast
3. Regional Markets
3.1 The US
3.1.1 The US Glaucoma Drugs Market Forecast by Value
3.1.2 The US Glaucoma Patient Volume Forecast
3.1.3 The US Open Angle Glaucoma Patient Volume Forecast
3.1.4 The US Glaucoma Prescription Volume Forecast
3.1.5 The US Glaucoma Drugs Market by Type
3.1.6 The US Glaucoma First Line Drugs Market Forecast by Value
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save time
and money for our clients. We are a one stop solution for all your
research needs, our main offerings are syndicated research reports,
custom research, subscription access and consulting services. We serve
all sizes and types of companies spanning across various industries.
Contact
Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074
No comments:
Post a Comment